参考文献/References:
[1] MARTINEZ-LOPEZ A,BLASCO-MORENTE G,GIRON-PRIETO M S,et al.Linking of psoriasis with osteopenia and osteoporosis:a cross-sectional study[J].Indian J Dermatol Venereol Leprol,2019,85(2):153-159.
[2] KHOSLA S,MELTON L J.Osteopenia[J].N Engl J Med,2007,356(22):2293-2300.
[3] ASPRAY T J,HILL T R.Osteoporosis and the ageing skeleton[J].Subcell Biochem,2019,91:453-476.
[4] 魏百川,周鹏,竺琼,等.基于Markov模型的社区骨质疏松人群健康状态预测研究[J].上海医药,2021,42(14):35-39.
[5] MACKNIGHT J M.Osteopenia and osteoporosis in female athletes[J].Clin Sports Med,2017,36(4):687-702.
[6] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
[7] 朱洁云,高敏,宋秋韵,等.中国老年人骨质疏松症患病率的Meta分析[J].中国全科医学,2022,25(3):346-353.
[8] LIU J,MA L,BI Y,et al.A population-based study examining calcaneus quantitative ultrasound and its optimal cut-points to discriminate osteoporotic fractures among 9352 chinese women and men[J].The Journal of Clinical Endocrinology & Metabolism,2012,97(3):800-809.
[9] MCCLOSKEY E V,HARVEY N C,JOHANSSON H,et al.Fracture risk assessment by the FRAX model[J].Climacteric:the Journal of the International Menopause Society,2022,25(1):22-28.
[10] 吴苗,唐兰,王钰麒,等.探索中老年男性骨量减少和骨质疏松的相关因素[J].中国骨质疏松杂志,2021,27(9):1279-1282.
[11] 马艳琦,刘露霞,王瑛,等.中老年2型糖尿病患者血清FGF21、FGF23水平与骨量异常关系的研究[J].中国骨质疏松杂志,2022,28(2):157-161.
[12] 金珉廷,郑洪新.骨质疏松症的中医体质学特征[J].中华中医药学刊,2009,27(4):824-826.
[13] ZHU X,ZHENG H.Factors influencing peak bone mass gain[J].Frontiers of Medicine,2021,15(1):53-69.
[14] CHEW C K,CLARKE B L.Causes of low peak bone mass in women[J].Maturitas,2018,111:61-68.
[15] SIDDIQUI J A,PARTRIDGE N C.Physiological bone remodeling:systemic regulation and growth factor involvement[J].Physiology,2016,31(3):233-245.
[16] LIU C,HE Y,XU X,et al.The study of natural compounds targeting rankl signaling pathway for the treatment of bone diseases[J].Current Drug Targets,2020,21(4):344-357.
[17] SCHUPBACH D,COMEAU-GAUTHIER M,HARVEY E,et al.Wnt modulation in bone healing[J].Bone,2020,138:115491.
[18] 徐克,樊金婷,周晓辉.原发性骨质疏松相关基因研究进展[J].临床医药文献电子杂志,2018,5(74):197-198.
[19] KANIS P A.Assessment of fracture risk and its application to screening for postmenopausal osteoporosis:synopsis of a WHO report[J].Osteoporosis Int,1994,4(6):368-381.
[20] 张萌萌,徐又佳,侯建明,等.骨质疏松实验室诊断及影响因素专家共识2022[J].中国骨质疏松杂志,2022,28(9):1249-1259.
[21] 陈德才,廖二元,徐苓,等.骨代谢生化标志物临床应用指南[J].中华骨质疏松和骨矿盐疾病杂志,2015,8(4):283-293.
[22] WU C H,CHANG Y F,CHEN C H,et al.Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region[J].J Clin Densitom,2021,24(1):3-13.
[23] 金丹,袁慧书.影像学定量骨结构评估方法在骨质疏松症中的应用进展[J].中国骨质疏松杂志,2022,28(5):738-743.
[24] 程晓光,袁慧书,程敬亮,等.骨质疏松的影像学与骨密度诊断专家共识[J].中国骨与关节杂志,2020,9(9):666-673.
[25] 陈明月,张雪丽,汤光宇.基于CT的机会性筛查评估骨质疏松症的研究进展[J].国际医学放射学杂志,2022,45(4):459-465.
[26] 尚德阳.瘀血与骨质疏松症关系研究[J].辽宁中医药大学学报,2008(9):40-41.
[27] 尚德阳,郑洪新.基于“络病”理论的骨质疏松症病机探微[J].中华中医药学刊,2008(2):344-345.
[28] 葛继荣,王和鸣,郑洪新,等.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,26(12):1717-1725.
[29] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-444.
[30] LI D H,YANG Z Y,WEI Z,et al.Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis:A PRISMA-compliant meta-analysis of animal studies and clinical trials[J].Sci Rep,2018,8:1450.
[31] WEIN M N,KRONENBERG H M.Regulation of bone remodeling by parathyroid hormone[J].Cold Spring Harbor Perspectives in Medicine,2018,8(8):a31237.
[32] BÖRZSEI D,SZAB R,HOFFMANN A,et al.Distinct approaches of raloxifene:its far-reaching beneficial effects implicating the HO-system[J].Biomolecules,2020,10(3):375.
[33] KOODZIEJSKA B,STEPIE'N N,KOLMAS J.The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment[J].International Journal of Molecular Sciences,2021,22(12):6564.
[34] COSMAN F.Anabolic and antiresorptive therapy for osteoporosis:combination and sequential approaches[J].Current Osteoporosis Reports,2014,12(4):385-395.
[35] IZQUIERDO M,MERCHANT R A,MORLEY J E,et al.International exercise recommendations in older adults(ICFSR):expert consensus guidelines[J].J Nutr Health Aging,2021,25(7):824-853.
[36] 王梅,郭曼,吴静,等.膳食炎症指数与骨质疏松、骨折风险关系的Meta分析[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(1):57-65.
[37] 王春昕,杨利丽,李秋菊.健康教育对骨质疏松性骨折患者生活方式及生存质量的影响[J].检验医学与临床,2016,13(4):537-539.